Common Stock, Shares, Outstanding of Moleculin Biotech, Inc. from Q4 2015 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Moleculin Biotech, Inc. quarterly Common Stock, Shares, Outstanding history and change rate from Q4 2015 to Q3 2025.
  • Moleculin Biotech, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 49.5M shares, a 1549% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Moleculin Biotech, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 49.5M +46.5M +1549% 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 30.2M +27.6M +1080% 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 14.1M +11.8M +511% 31 Mar 2025 10-Q 13 May 2025
Q4 2024 3.38M +1.15M +51.7% 31 Dec 2024 10-Q 13 Nov 2025
Q3 2024 3M -26.8M -89.9% 30 Sep 2024 10-Q 08 Nov 2024
Q2 2024 2.56M -27.2M -91.4% 30 Jun 2024 10-Q 13 Aug 2024
Q1 2024 2.31M -27.3M -92.2% 31 Mar 2024 10-Q 10 May 2024
Q4 2023 2.23M +319K +16.7% 31 Dec 2023 10-K 21 Mar 2025
Q3 2023 29.8M +1.18M +4.13% 30 Sep 2023 10-Q 13 Nov 2023
Q2 2023 29.8M +1.18M +4.13% 30 Jun 2023 10-Q 10 Aug 2023
Q1 2023 29.6M +1.02M +3.58% 31 Mar 2023 10-Q 10 May 2023
Q4 2022 1.91M -26.7M -93.3% 31 Dec 2022 10-K 22 Mar 2024
Q3 2022 28.6M +50.7K +0.18% 30 Sep 2022 10-Q 10 Nov 2022
Q2 2022 28.6M +54.5K +0.19% 30 Jun 2022 10-Q 12 Aug 2022
Q1 2022 28.6M +134K +0.47% 31 Mar 2022 10-Q 11 May 2022
Q4 2021 28.6M +17M +148% 31 Dec 2021 10-Q 10 Nov 2022
Q3 2021 28.6M -33.2M -53.7% 30 Sep 2021 10-Q 10 Nov 2021
Q2 2021 28.6M -31.9M -52.7% 30 Jun 2021 10-Q 11 Aug 2021
Q1 2021 28.4M -24.8M -46.6% 31 Mar 2021 10-Q 12 May 2021
Q4 2020 11.5M +3.92M +51.4% 31 Dec 2020 10-K 24 Mar 2022
Q3 2020 61.8M +16M +35.1% 30 Sep 2020 10-Q 12 Nov 2020
Q2 2020 60.4M +15.2M +33.6% 30 Jun 2020 10-Q 12 Aug 2020
Q1 2020 53.2M +18.8M +54.7% 31 Mar 2020 10-Q 11 May 2020
Q4 2019 7.62M -20.9M -73.3% 31 Dec 2019 10-K 24 Mar 2021
Q3 2019 45.7M +18.9M +70.2% 30 Sep 2019 10-Q 12 Nov 2019
Q2 2019 45.2M +18.3M +68.3% 30 Jun 2019 10-Q 16 Aug 2019
Q1 2019 34.4M +8.64M +33.5% 31 Mar 2019 10-Q 13 May 2019
Q4 2018 28.5M +7.06M +32.9% 31 Dec 2018 10-K 19 Mar 2020
Q3 2018 26.9M +6.04M +29% 30 Sep 2018 10-Q 13 Nov 2018
Q2 2018 26.9M +6.7M +33.2% 30 Jun 2018 10-Q 10 Aug 2018
Q1 2018 25.8M +8.01M +45.1% 31 Mar 2018 10-Q 14 May 2018
Q4 2017 21.5M +9.3M +76.5% 31 Dec 2017 10-K 21 Feb 2019
Q3 2017 20.8M +8.77M +72.7% 30 Sep 2017 10-Q 13 Nov 2017
Q2 2017 20.2M +8.91M +79.2% 30 Jun 2017 10-Q 11 Aug 2017
Q1 2017 17.8M +11M +162% 31 Mar 2017 10-Q 12 May 2017
Q4 2016 12.2M +5.5M +82.6% 31 Dec 2016 10-K 28 Mar 2018
Q3 2016 12.1M 30 Sep 2016 10-Q 21 Nov 2016
Q2 2016 11.3M 30 Jun 2016 10-Q 21 Nov 2016
Q1 2016 6.79M 31 Mar 2016 10-Q 16 Jun 2016
Q4 2015 6.66M 31 Dec 2015 10-K 03 Apr 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.